IRIS
D'ANGELO, ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.451
AS - Asia 5.887
EU - Europa 4.689
SA - Sud America 899
Continente sconosciuto - Info sul continente non disponibili 232
AF - Africa 214
OC - Oceania 9
Totale 21.381
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.270
CN - Cina 2.977
SG - Singapore 1.280
IE - Irlanda 1.075
BR - Brasile 686
DE - Germania 665
UA - Ucraina 643
FI - Finlandia 579
HK - Hong Kong 563
RU - Federazione Russa 487
VN - Vietnam 486
FR - Francia 282
IT - Italia 272
SE - Svezia 240
GB - Regno Unito 237
IN - India 142
ZA - Sudafrica 125
CA - Canada 98
BD - Bangladesh 88
AR - Argentina 77
ID - Indonesia 43
IQ - Iraq 43
JP - Giappone 43
TR - Turchia 39
MX - Messico 37
NL - Olanda 35
ES - Italia 31
BE - Belgio 30
EC - Ecuador 28
PK - Pakistan 26
PL - Polonia 24
CO - Colombia 23
UZ - Uzbekistan 21
VE - Venezuela 21
PH - Filippine 20
PE - Perù 19
JO - Giordania 18
EG - Egitto 16
PY - Paraguay 16
TN - Tunisia 15
CZ - Repubblica Ceca 14
SA - Arabia Saudita 14
BO - Bolivia 13
MA - Marocco 13
MY - Malesia 13
CR - Costa Rica 12
CL - Cile 11
LT - Lituania 10
AE - Emirati Arabi Uniti 9
AT - Austria 9
IL - Israele 9
KZ - Kazakistan 8
MU - Mauritius 8
JM - Giamaica 7
KE - Kenya 6
RO - Romania 6
AZ - Azerbaigian 5
CH - Svizzera 5
ET - Etiopia 5
MK - Macedonia 5
NI - Nicaragua 5
NP - Nepal 5
SN - Senegal 5
TH - Thailandia 5
AL - Albania 4
DZ - Algeria 4
HU - Ungheria 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
AM - Armenia 3
AU - Australia 3
BA - Bosnia-Erzegovina 3
GE - Georgia 3
GR - Grecia 3
HN - Honduras 3
KR - Corea 3
MG - Madagascar 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
PS - Palestinian Territory 3
UY - Uruguay 3
BG - Bulgaria 2
BH - Bahrain 2
DJ - Gibuti 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GA - Gabon 2
GT - Guatemala 2
IS - Islanda 2
KG - Kirghizistan 2
KH - Cambogia 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
NC - Nuova Caledonia 2
PR - Porto Rico 2
QA - Qatar 2
Totale 21.117
Salva come PNG Salva come JPEG
Città #
Dublin 1.075
San Jose 927
Chandler 894
Jacksonville 848
Ashburn 678
Nanjing 655
Singapore 646
Dallas 586
Hong Kong 549
Beijing 424
Boardman 327
Nanchang 287
Council Bluffs 256
Munich 204
Shenyang 201
Los Angeles 200
Princeton 195
Lauterbourg 190
Lawrence 190
Medford 187
Helsinki 185
Hebei 180
Ho Chi Minh City 174
Wilmington 174
Changsha 172
Jiaxing 162
Hanoi 118
Johannesburg 114
Hangzhou 112
New York 110
Tianjin 102
Santa Clara 93
Ann Arbor 90
Redondo Beach 88
Buffalo 87
Moscow 86
Shanghai 78
São Paulo 74
Orem 64
Atlanta 53
Woodbridge 53
Cambridge 51
Milan 51
Turku 50
Toronto 45
San Francisco 42
Seattle 42
Tokyo 37
Chennai 34
Montreal 33
Piscataway 32
Pavia 28
Brussels 27
Brooklyn 26
Fairfield 26
Phoenix 26
Pune 26
Rio de Janeiro 26
Des Moines 25
Frankfurt am Main 25
Chicago 24
Denver 24
Norwalk 24
Jinan 22
Kunming 21
London 21
Baghdad 20
Da Nang 20
Stockholm 20
Guangzhou 19
Haiphong 19
The Dalles 19
Boston 18
Tashkent 18
Verona 17
Houston 16
Ankara 15
Belo Horizonte 15
Columbus 15
Falkenstein 14
Quito 14
Warsaw 14
Amman 13
Campinas 13
Charlotte 13
Dhaka 13
Taizhou 12
Washington 12
Zhengzhou 12
Bắc Ninh 11
Manchester 11
Ningbo 11
Orange 11
Poplar 11
Rome 11
Curitiba 10
Salvador 10
Amsterdam 9
Biên Hòa 9
Bogotá 9
Totale 13.150
Salva come PNG Salva come JPEG
Nome #
Effect of Diazepam on 24-Hour Blood Pressure and Heart Rate in Healthy Young Volunteers 733
Safety and efficacy of alpha lipoic acid during 4 years of observation: A retrospective, clinical trial in healthy subjects in primary prevention 341
Effects of oral administration of alprazolam and lorazepam as hypnotics on cardiovascular parameters in hypertensive patients. 313
Evaluation of the Effect on Sexual Performance of a Nutraceutical Combination Containing Alpha Lipoic Acid, Vitis vinifera L. and Ginkgo biloba, Compared to Placebo, Avanafil or a Combination of Nutraceutical Plus Avanafil in Males With Type 2 Diabetes Mellitus With Erectile Dysfunction 309
Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial 245
Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial 189
Effect of Evening Bromazepam Administration on Blood Pressure and Heart Rate in Mild Hypertensive Patients 178
Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation. 167
A possible way to improve the glycemic control and the beta cell function during three years: the triple therapy. 159
Plasma eotaxin concentrations are associated with angiographic severity of coronary artery disease 158
An evaluation of a nutraceutical with berberine, curcumin, inositol, banaba and chromium picolinate in patients with fasting dysglycemia 147
Absence of Kir6.1/KCNJ8 mutations in Italian patients with abnormal coronary vasomotion 146
Abscisic Acid Treatment in Patients with Prediabetes. 144
Relationship between apolipoprotein(a) size polimorphism and coronary heart disease in overweight subjects 143
The Apolipoprotein(a) Component of Lipoprotein(a) Mediates Binding to Laminin: Contribution to Selective Retention of Lipoprotein(a) in Atherosclerotic Lesions 141
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia 140
Relationship between plasma levels of soluble receptor for advanced glycation end products (sRAGE) and coronary artery disease 140
RAGE : a central player in nondiabetic vascular disease 138
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men 137
Galectin-3 plasma levels andcoronary artery disease: a new possible biomarker of acute coronary syndrome. 136
Probiotic Therapy With VSL#3® in Patients With NAFLD: A Randomized Clinical Trial 135
Confronto tra nateglinide più metformina rispetto a glibenclamide più metformina sul metabolismo glucidico nei pazienti diabetici di tipo 2: studio ad 1 anno 134
The apolipoprotein(a) component of lipoprotein(a) mediates binding to laminin:contribution to selective retention of lipoprotein(a) in atherosclerotic lesions. 133
Different actions of losartan and ramipril on adipose tissue Activity and vascular remodeling biomarkers in hypertensive patients 133
The regulatory chemokine eotaxin-3 is a novel predictor of cardiovascular outcome in patients with coronary artery disease 132
A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients 132
Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension 131
Azione della moxonidina sul metabolismo glucidico e lipidico negli ipertesi con sindrome metabolica 131
Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study 130
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus. 130
Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load 127
Diazepam as an oral hypnotic increases nocturnal blood pressure in the elderly. 126
Effects of combination of sibutramine and L-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients 126
Effetti metabolici di telmisartan e irbesartan nei pazienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone 125
Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery disease 125
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus 125
Differential effect of candesartan and olmesartan on adipose tissue activity biomarkers in type 2 diabetic hypertensive patients 124
A clinical trial about a food supplement containing α-lipoic acid on oxidative stress markers in type 2 diabetic patients 124
Effetti di pioglitazone e rosiglitazone nei pazienti con diabete di tipo 2 e sindrome metabolica trattati con metformina 123
Acarbose compared to placebo on insulin resistance biomarkers in a double-blind, placebo-controlled trial 122
Biomarcatori infiammatori e neuro-ormonali nella fibrillazione atriale persistente; ruolo prognostico della concentrazione plasmatica di apelina 121
High levels of soluble receptor for advanced glycation end products may be a marker of extreme longevity in humans 119
CORRELAZIONE TRA I LIVELLI PLASMATICI DI NEUROTROFINE, SINTOMATOLOGIA DEPRESSIVA E ATEROSCLEROSI CORONARICA 119
Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients 118
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial 117
ATPases of synaptic plasma membranes and vesicles from rat cerebral cortex during aging and hypoxia 115
Correlazione tra livelli plasmatici di galactina e aterosclerosi coronarica: nuovo marcatore di instabilità clinica? 115
A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk 115
Differenti effetti di candesartan e olmesartan sui parametri di attività del tessuto adiposo in pazienti diabetici di tipo 2 ipertesi 114
Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome 113
Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patients 113
Variation of inflammatory parameters after sibutramine treatment compared to placebo in type 2 diabetic patients 112
Effetti di un anno di trattamento con vildagliptin associato a pioglitazone o glimepiride in pazienti diabetici scarsamente controllati 112
Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses. 111
Effect of flunitrazepam as an oral hypnotic on 24-hour blood pressure in healthy volunteers. 111
Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients 110
Elevated plasma levels of lipoprotein(a) in psychiatric patients: a possible contribution to increased vascular risk 109
Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone 109
Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study 109
Metalloproteasi-2, metalloproteasi-9 ed inibitore tissutale delle metalloproteasi-1 in pazienti ipertesi 108
The efficacy and safety of pioglitazone or rosiglitazone added onto metformin in type 2 diabetes patients with metabolic syndrome 108
Twenty-four-hour blood pressure profile, orthostatic hypotension, and cardiac dysautonomia in elderly type 2 diabetic hypertensive patients 108
Effetti di un anno di trattamento con orlistat+L-carnitina paragonato a orlistat o placebo sui parametri di insulino-resistenza nei pazienti diabetici 107
Relationship between sRAGE and eotaxin-3 with CRP in hypertensive patients at high cardiovascular risk. 107
Low plasma apelin levels predict arrhythmia recurrence in patients with persistent atrial fibrillation 107
Ambulatory 24-h ECG monitoring and cardiovascular autonomic assessment for the screening of silent myocardial ischemia in elderly type 2 diabetic hypertensive patients 107
Lipoprotein (a) Particles Characterization by Dynamic Light Scattering 107
Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus 106
Benzodiazepins and cardiovascular risk: recent acquisitions and revision of literature. 106
Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride 105
Effetti metabolici di telmisartan e di irbesartan in pazienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone: un trial clinico randomizzato a doppio cieco 105
Markers of eosinophilic inflammation and risk prediction in patients with coronary artery disease 105
Action of L-acetylcarnitine on different cerebral mitochondrial populations from cerebral cortex 105
Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease 105
Telmisartan ed irbesartan nei diabetii di tipo 2 trattati con rosiglitazone: effetti sull'insulino-resistenza, la leptine e il TNF-alfa 104
Effetti dell'associazione tra pioglitazone e sibutramina sul metabolismo glucidico e lipidico nei soggetti obesi diabetici di tipo 2 104
Effect of in vivo administration of naloxone on ATP-ase's enzyme systems of synaptic plasma membranes from rat cerebral cortex 103
Le metalloprotesi -2 e -9 e i loro inibitori tissutali -1 e -2 nei soggetti sani e nei soggetti con diabete di tipo 2 103
MMP-2, -9 and TIMP-1 in patients with hypertension before and after doxazosin therapy 103
Effects of berberine on lipid profile in subjects with low cardiovascular risk 102
Microalbuminuria and sRAGE in High-Risk Hypertensive Patients Treated with Nifedipine/Telmisartan Combination Treatment: A Substudy of TALENT 102
Effects of a combination of Berberis aristata, Silybum marianum and monacolin on lipid profile in subjects at low cardiovascular risk; a double-blind, randomized, placebo-controlled trial 101
Circulating levels of soluble receptor for advanced glycation end products in neurodegenerative and vascular dementia 100
Effetti metabolici di telmisartan e irbesartan nei apzienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone 100
Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin 99
Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome 99
The efficacy and safety of pioglitazone or rosiglitazone added onto metformin on diabetic dyslipidemia 97
Synergistic effect of doxazosin and acarbose in improving metabolic control in patients with impaired glucose tolerance 97
Prevalence of erectile dysfunction in males affected by type 2 diabetes and the impact of hyperinsulinemia 95
Berberis aristata/Silybum marianum fixed combination (Berberol®) effects on lipid profile in dyslipidemic patients intolerant to statins at high dosages: A randomized, placebo-controlled, clinical trial. 95
Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients 94
Continuous glucose monitoring system in free-living healthy subjects: results from a pilot study 94
Candesartan effect on inflammation in hypertension 94
Prevalence and associations of erectile dysfunction in a sample of italian males with type 2 diabetes. 94
A role for quercetin in coronavirus disease 2019 (COVID-19) 93
Efficacia e sicurezza di pioglitazone o rosiglitazone in combinazione con metformina in pazienti con diabete di tipo 2 e sindrome metabolica 93
A randomized, double-blind, placebo-controlled study to evaluate the effectiveness of a food supplement containing creatine and d-ribose combined with a physical exercise program in increasing stress tolerance in patients with ischemic heart disease 92
Matrix metalloproteinases and tissue inhibitor metalloproteinases in hypertensive patients 92
Matrix metalloproteinase-2 and – 9 levels in obese patients 91
Ascophyllum nodosum and Fucus vesiculosus on glycemic status and on endothelial damage markers in dysglicemic patients 91
Totale 13.062
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.659
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.659
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022728 0 4 30 5 6 10 5 46 44 15 119 444
2022/20232.855 286 200 20 189 282 283 2 163 1.253 35 89 53
2023/2024964 110 179 27 57 87 223 3 100 9 39 61 69
2024/20252.899 28 235 88 73 57 145 234 240 688 87 315 709
2025/20266.710 551 420 831 714 730 272 1.336 305 581 484 312 174
2026/20271.978 1.048 930 0 0 0 0 0 0 0 0 0 0
Totale 21.381